Promotion of Healthy Lifestyle Habits in Primary Care Settings

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-70
SponsorÖrebro University, Sweden

About this trial

Intervention aiming to promote healthy dietary and physical activity behaviors in adults with different socioeconomic status primary care settings

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age, high metabolic risk- poor lifestyle habits (diet and physical activity)

Disqualifiers

overt disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Healthy lifestyle counseling and E-health support

    Behavioral

    Promotion of healthy lifestyle behaviors through counseling and access to E-health platform

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Health counselling plus E-health platformExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in blood glucose level

Blood glucose (mmol/L) assessed using chemistry kits from Ortho-Clinical Diagnostics on a Vitros-5.1 analyzer platform (Clinical Diagnostics, Raritan, NJ, United States)

Time frame
Before ; at 16 weeks; at 12 months
2

Change in plasma triglycerides level

Plasma triglycerides (mmol/L) : assessed using chemistry kits from Ortho-Clinical Diagnostics on a Vitros-5.1 analyzer platform (Clinical Diagnostics, Raritan, NJ, United States)

Time frame
Before ; at 16 weeks; at 12 months
3

Change in physical activity level

Minutes in moderate to vigorous physical activity

Time frame
Before; at 16 weeks; at 12 months
4

Change in intakes of healthy food items

number of portions of fruits and vegetables

Time frame
Before; at 16 weeks; at 12 months

Secondary outcomes

1

Change in waist circumference

waist circumference (cm) assessed by a steel tape

Time frame
Before ; at 16 weeks; at 12 months
2

Change in systolic and diastolic blood pressure

measured manually with a mercury sphygmomanometer

Time frame
Before ; at 16 weeks; at 12 months
3

Change in HDL-cholesterol level

plasma High density lipoprotein- cholesterol: assessed using chemistry kits from Ortho-Clinical

Time frame
Before ; at 16 weeks; at 12 months
4

Change in BMI

BMI in kg/m2

Time frame
Before ; at 16 weeks; at 12months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.